NEW YORK — The federal government has given national security clearance to the controversial purchase of an American DNA sequencing company by a Chinese firm.

BGI-Shenzhen said over the weekend that its acquisition of Complete Genomics, of Mountain View, Calif., had been cleared by the Committee on Foreign Investment in the United States, which reviews the national security implications of foreign takeovers of US companies.